PlainRecalls

Blenheim Pharmacal, Inc.

Compiled from official public sources by the publisher.

2 recalls on record · Latest: Jun 3, 2015

Subscribe to new Blenheim Pharmacal, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Blenheim Pharmacal, Inc. LIGHT-BOOK · SINGLE-AGENCY

#4,444 of 14,151 · 2 notices · 0.002% archive

  • BOOK 2 notices
  • RANK #4,444 of 14,151
  • SHARE 0.002% archive
  • AGENCY FDA Drug (2)
  • CAT drugs
  • CATS 1 category
  • LATEST Jun 3, 2015
  • PHOTO 3M Company

Nearest notice-volume peer: 3M Company (0 notice gap)

Blenheim Pharmacal, Inc. accounts for about 0.002% of the 104,423-notice archive on 2 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Blenheim Pharmacal, Inc.'s standing among 14,151 recalling firms

Blenheim Pharmacal, Inc. ranks 4,444th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Blenheim Pharmacal, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

2 4444th of 14151 higher than 8,037 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-20

Blenheim Pharmacal, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Blenheim Pharmacal, Inc. holds about 0.002% of archive notices alongside 2 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Jun 3, 2015

Captopril Tablets, USP, 50 mg, 30 Tablets, Rx Only, Dist. By: Wockhardt USA LLC, Parsippany, NJ 07054, Packaged By: Blenheim Pharmacal Inc. North Blenheim, NY 12131, NDC 10544-175-30, MFG: 64679-904-02
FDA Drug Moderate Jun 3, 2015

Clarithromycin Tablets, USP, 500 mg, 20 Tablets, Rx Only, Dist. By: Wockhardt USA LLC, Parsippany, NJ 07054, Repackaged By: Blenheim Pharmacal Inc. North Blenheim, NY 12131, NDC 10544-522-20, MFG: 64679-904-02

Blenheim Pharmacal, Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Blenheim Pharmacal, Inc.? ▼
PlainRecalls indexes 2 distinct federal recall events naming Blenheim Pharmacal, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Blenheim Pharmacal, Inc. sit among other recalling firms? ▼
Blenheim Pharmacal, Inc. ranks #4,444 of 14,151 by distinct recall-event count among 14,151 firms in this archive (57th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Blenheim Pharmacal, Inc.'s notices? ▼
FDA Drug accounts for 2 of this firm's 2 indexed notices.
What product category dominates Blenheim Pharmacal, Inc.'s filing book? ▼
Filings for Blenheim Pharmacal, Inc. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Blenheim Pharmacal, Inc.: 2 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Blenheim Pharmacal, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026